H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection

Cell

Volumn 84, Issue 4, 1996, Pages 543-550

  Martin, W David ^a   Hicks, Geoffrey G ^a   Mendiratta, Sanjeev K ^a   Leva, Hitesh I ^a   Ruley, H Earl ^a   Van Kaer, Luc ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN SUBUNIT;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; GENE MUTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030048126     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81030-2     Document Type: Article

References (42)

1. + T cells in TAP1 mutant mice. Proc. Natl. Acad. Sci. USA 91, 6525-6528.
2. Ashton-Rickardt, P.G., and Tonegawa, S. (1994). A differential-avidity model for T-cell selection. Immunol. Today 15, 362-366.
3. + T cells in the thymus. Cell 73, 1041-1049.
4. Ashton-Rickardt, P.G., Bandeira, A., Delaney, J.R., Van Kaer, L., Pircher, H.P., Zinkernagel, R.M., and Tonegawa, S. (1994). Evidence for a differential avidity model of T cell selection in the thymus. Cell 76, 1464-1473.
5. Avva, R.R., and Cresswell, P. (1994). In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1, 763-774.
6. k class II molecules in human APC containing deleted or mutated HLA DM genes. J. Immunol. 153, 5382-5392.
7. Ceman, S., Rudersdorf, R., Long, E.O., and DeMars, R. (1992). MHC class II deletion mutant expresses normal levels of transgene encoded class II molecules that have abnormal conformation and impaired antigen presentation ability. J. Immunol. 149, 754-761.
8. Cho, S.G., Attaya, M., and Monaco, J.J. (1991). New class II-like genes in the murine MHC. Nature 353, 573-576.
9. Cresswell, P. (1994). Assembly, transport and function of MHC class II molecules. Annu. Rev. Immunol. 12, 259-293.
10. Denzin, L.K., and Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82, 155-165.
11. Denzin, L.K., Robbins, N.F., Carboy-Newcomb, C., and Cresswell, P. (1994). Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1, 595-606.
12. Eastman, S., Deftos, M., DeRoos, P.C., Hsu, D.-H., Teyton, L., Braunstein, N.S., Hackett, C.J., and Rudensky, A. (1996). A study of invariant chain peptide CLIP:MHC class II complexes using new complex-specific monoclonal antibody. Eur. J. Immunol., in press.
13. Fling, S.P., Arp, B., and Pious, D. (1994). HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368, 554-558.
14. Germain, R.N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299.
15. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D.C. (1995). The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378, 457-462.
16. 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I. J. Exp. Med. 179, 661-672.
17. + T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J. Exp. Med. 177, 1469-1473.
18. Hogquist, K.A., Jameson, S.C., Heath, W.R., Howard, J.L., Bevan, M.J., and Carbone, F.R. (1994). T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27.
19. Karlsson, L., Péléraux, A., Lindstedt, R., Liljedahl, M., and Peterson, P.A. (1994). Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 266, 1569-1573.
20. Kelly, A.P., Monaco, JJ., Cho, S.G., and Trowsdale, J. (1991). A new human HLA class II-related locus, DM. Nature 353, 571-573.
21. Kropshofer, H., Vogt, A.B., Stern, L.J., and Hämmerling, G.J. (1995). Self-release of CLIP in peptide loading of HLA-DR molecules. Science 270, 1357-1359.
22. Mellins, E., Smith, L., Arp, B., Cotner, T., Celis, E., and Pious, D. (1990). Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343, 71-74.
23. Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J.J., and Mellins, E. (1994). An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368, 551-554.
24. Murphy, D.B., Lo, D., Rath, S., Brinster, R.L., Flavell, R.A., Slanetz, A., and Janeway, C.A., Jr. (1992). Monoclonal antibody detection of a major self peptide-MHC class II complex. J. Immunol. 148, 3483-3491.
25. Newcomb, J.R., and Cresswell, P. (1993). Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated αβ dimers. J. Immunol. 150, 499-507.
26. Nossal, G.J.V. (1994). Negative selection of lymphocytes. Cell 76, 219-228.
27. Riberdy, J.M., and Cresswell, P. (1992). The antigen processing mutant T2 suggests a role for MHC-linked genes in antigen presentation. J. Immunol. 148, 2586-2590.
28. Riberdy, J.M., Newcomb, J.R., Surman, M.J., Barbosa, J.A., and Cresswell, P. (1992). HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360, 474-477.
29. Roche, P.A., and Cresswell, P. (1991). Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345, 615-618.
30. Rudensky, A.Y., Rath, S., Preston-Hurlburt, P., Murphy, D., and Janeway, C.A., Jr. (1991). On the complexity of self. Nature 353, 660-662.
31. Sanderson, F., Kleijmeer, M.J., Kelly, A., Verwoerd, D., Tulp, A., Neefjes, J.J., Geuze, H.J., and Trowsdale, J. (1994). Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266, 1566-1569.
32. Sanderson, F., Thomas, C., Neefjes, J., and Trowsdale, J. (1996). Association between HLA-DM and HLA-DR in vivo. Immunity 4, 87-96.
33. Schmid, S.L., and Jackson, M.R. (1994). Making class II presentable. Nature 369, 103-104.
34. Sebzda, E., Wallace, V.A., Mayer, J., Yeung, R.S.M., Mak, T.W., and Ohashi, P.S. (1994). Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science 263, 1615-1618.
35. Sette, A., Ceman, S., Kubo, R.T., Sakaguchi, K., Appella, E., Hunt, D.F., Davis, T.A., Michel, H., Shabanowitz, J., Rudersdorf, R., Grey, H.M., and DeMars, R. (1992). Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258, 1801-1804.
36. Sherman, M.A., Weber, D.A., and Jensen, P.E. (1995). DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3, 197-205.
37. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., and Zaller, D.M. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
38. Stebbins, C.C., Loss, G.E., Jr., Elias, C.G., Chervonsky, A., and Sant, A.J. (1995). The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species specific. J. Exp. Med. 181, 223-234.
39. Teyton, L., O'Sullivan, D., Dickson, P.W., Loteau, V., Sette, A., Fink, P., and Peterson, P.A. (1990). Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348, 39-44.
40. + T cells. Cell 71, 1205-1214.
41. von Boehmer, H. (1994). Positive selection of lymphocytes. Cell 76, 219-228.
42. Wolf, P.R., and Ploegh, H.L (1995). How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Dev. Biol. 11, 267-306.